Clinical Nurse Specialist, Acute Care · Oklahoma City, OK
NPI
1124512686
Since 2018
Specialty
Clinical Nurse Specialist, Acute Care
Code 364SA2100X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
5224 E I 240 Service Rd
Oklahoma City, OK, 73135
Phone (405) 608-3800
Groups this clinician bills Medicare through
Medicare paid, 2024
$62K
1,534 services
Medicare patients, 2024
287
Average age 72
Drug cost, 2024
$3.2M
3,615 prescriptions
Company payments, 2025
$3,481
From 28 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Deborah Peter was code 82962 (clinical chemistry), 332 times for 232 patients. In total Deborah Peter billed 1,534 services in 14 codes, and Medicare paid $62K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-03-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 82962 Clinical Chemistry | Office | 332 | 232 | $3.20 | $1,063 |
| 83036 Blood Count | Office | 328 | 230 | $9.50 | $3,114 |
| 99214 Office E&M - Established | Office | 300 | 195 | $71.89 | $22K |
| 99215 Office E&M - Established | Office | 246 | 179 | $102.89 | $25K |
| 95251 Test - Miscellaneous | Office | 244 | 139 | $21.62 | $5,276 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 38 | 34 | $19.21 | $730 |
| 99205 Office E&M - New | Office | 31 | 31 | $125.35 | $3,886 |
By year: 2022 $54K for 1,714 services; 2023 $59K for 1,732 services; 2024 $62K for 1,534 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 332 | 232 | $3.20 | $1,063 |
| 83036 Blood Count | 328 | 230 | $9.50 | $3,114 |
Medicare prescription drug claims, 2024
In 2024, the drug Deborah Peter prescribed most often to Medicare patients was Ozempic (Semaglutide), with 480 prescriptions and refills. In total Deborah Peter wrote 3,615 Medicare prescriptions that cost $3.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 480 | 904 | 116 | $865K |
| Mounjaro Tirzepatide | 273 | 402 | 54 | $423K |
| Tresiba Flextouch U-200 Insulin Degludec | 211 | 460 | 67 | $322K |
| Jardiance Empagliflozin | 209 | 420 | 52 | $245K |
| Trulicity Dulaglutide | 183 | 289 | 46 | $278K |
| Metformin Hcl Er Metformin Hcl | 167 | 469 | 56 | $1,710 |
| Metformin Hcl Generic | 156 | 464 | 55 | $1,471 |
| Levothyroxine Sodium Generic | 143 | 401 | 41 | $1,239 |
| Farxiga Dapagliflozin Propanediol | 101 | 211 | 26 | $111K |
| Toujeo Max Solostar Insulin Glargine,hum.Rec.Anlog | 94 | 205 | 30 | $125K |
| Omnipod 5 Dexg7g6 Pods (Gen 5) Insulin Pump Cart,auto,bt,g6/7 | 92 | 160 | 21 | $123K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 86 | 209 | 38 | $9,955 |
| Glipizide Er Glipizide | 82 | 218 | 27 | $1,593 |
| Pioglitazone Hcl Generic | 71 | 204 | 24 | $948 |
| Novolog Flexpen Insulin Aspart | 71 | 149 | 35 | $31K |
Brand drugs: 2,391 claims; generic drugs: 922 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Deborah Peter $3,481 ($3,481 in general payments such as food, travel and fees) from 28 companies. The largest payer was Tandem Diabetes Care, Inc. with $2,026.
| Company | Payments | Amount |
|---|---|---|
| Tandem Diabetes Care, Inc. TNDM | 6 | $2,026 |
| Novo Nordisk Inc NVO | 4 | $186 |
| Xeris Pharmaceuticals, Inc. | 11 | $180 |
| Madrigal Pharmaceuticals MDGL | 3 | $111 |
| Sanofi-Aventis U.S. LLC SNY | 4 | $106 |
| Kite Pharma, Inc. GILD | 1 | $94.58 |
| Lilly USA, LLC LLY | 5 | $89.41 |
| Corcept Therapeutics CORT | 4 | $77.29 |
| Ascendis Pharma Endocrinology Inc ASND | 4 | $73.71 |
| Amgen Inc. AMGN | 4 | $68.36 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.